Detecting cancer in a few minutes with a simple blood test: Scientists at the University of Fribourg are one step closer to achieving this goal. With a new nanosensor, they can detect biomarkers originating from cancer quickly and precisely.

A swiss research team has grown artificial mini bladder tumours in the laboratory, on which drugs can be tested. According to the researchers, this could play an important role in the development of personalised therapies.

An adaptor makes immune cells fight cancer cells. Such “BiTE” agents have already proven effective against blood, lung and prostate cancer, researchers report.

Researchers from Switzerland and France have started to develop a brassiere that detects breast cancer at an early stage. Such a smart bra would be considerably cheaper than a mammography, a fact that would benefit women in impoverished countries in particular.

According to a new study, tiny plastic particles can be passed on during cell division. This could potentially favour the spread of cancer.

Doctors who use artificial intelligence (AI) to diagnose skin lesions achieve a slightly higher detection rate than their colleagues who do not use AI, namely 77 percent compared to 63.6 percent. In particular, inexperienced physicians benefit from AI support.

Artificial intelligence could revolutionize medical diagnostics – for example the algorithm developed by the pathologist Viktor Kölzer. But this revolution requires data. And data requires protection.

Where reality ends, Gerd Reis’ “Augmented Vision” begins: This is the name of the department at the German Research Center for Artificial Intelligence, where the computer scientist teaches machines not just to see – but also to understand.

Swiss researchers have filmed for the first time how a drug was activated in the body with light. This film could give the development of such drugs a decisive boost.